About: Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 20 July 2009

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2009 (ast) наукова стаття, опублікована в липні 2009 (uk) scientific article published on 20 July 2009 (en) مقالة علمية نشرت في 20 يوليو 2009 (ar)
publication date	wds:Q37284889-6384AE2C-E9BC-402F-8259-2C19FC532373
publication date	2009-07-20 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37284889-0400CFFC-1E1C-4CB9-9749-3938A954C59F
language of work or name	English
cites work	wds:Q37284889-01D26375-2B6B-4B0F-A906-AFA6A3CA4276 wds:Q37284889-07578AB2-7713-458B-96B2-C5A696498A09 wds:Q37284889-0F713BBF-8DC5-4478-BCD3-A2F1A9D6309D wds:Q37284889-152968BF-94D2-42D4-93FD-74D16C16AE24 wds:Q37284889-1E0C83B0-4DB3-4BD9-82EA-C04461302E9C wds:Q37284889-1E433A70-A3AC-4AE2-AB63-641FC1262A74 wds:Q37284889-240C756B-5963-4098-A3C0-3F3827CB48CC wds:Q37284889-289871A6-B61D-4AE8-929B-19E9C0F632C8 wds:Q37284889-31A20F7E-EB5F-468E-A64C-CC01EE71DF04 wds:Q37284889-34B462EE-6C04-4A8C-995F-2D1B46CF4AE9 wds:Q37284889-4AB3F910-F772-48FA-8305-5380C387CFB1 wds:Q37284889-4D068AD0-4C50-4B27-9900-3C4CBC201996 wds:Q37284889-615B5F91-E09A-4936-9B9E-D95117B747A6 wds:Q37284889-692E83F7-52C2-41E8-AC2D-653368484654 wds:Q37284889-87D1D74F-9767-4FD8-BCE3-DA1A8F26644F wds:Q37284889-94EAE679-D18B-4F8F-B10D-A517C85E936A wds:Q37284889-9752AC53-13F1-4BB7-A9C6-04B49A5C371D wds:Q37284889-97FF35C8-598F-4C2B-9E9D-25C5C82D9D2D wds:Q37284889-AB452B23-D1B7-4000-86D9-0479B29F4BC4 wds:Q37284889-B5088879-7B1C-46A8-A1B4-6333C2C11015 wds:Q37284889-B534F04B-76AB-4503-B61A-FDFEE870C74A wds:Q37284889-BE7584B8-598A-4BA3-B9E4-A12A9156FBC4 wds:Q37284889-D812A48E-264D-4881-A08C-FF4A53DE3A37 wds:Q37284889-D906F4BC-2B08-4B7A-9912-4F179854974C wds:Q37284889-D9BB77AE-D76C-4B07-88B3-BA31DA4FF8B0 wds:Q37284889-DC9E323E-29E6-427E-B9CC-DF7F7BB887D8 wds:Q37284889-E2AC9DC4-B494-4709-B0DF-244EA3AFEA45 wds:Q37284889-E3823D08-4300-4E5B-A03F-D3EDC2FCFFE0 wds:Q37284889-EECB9EE0-61F8-4A3E-8CAF-CB2EEE850E17 wds:Q37284889-F26EF12F-82C8-4D2E-A227-88B74A89EFE8
cites work	Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper Measurement of health status. Ascertaining the minimal clinically important difference The effect of tiotropium on exacerbations and airflow in patients with COPD. Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium Minimal important difference of the transition dyspnoea index in a multinational clinical trial Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Evidence-Based Health Policy---Lessons from the Global Burden of Disease Study A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire Chronic obstructive pulmonary disease surveillance--United States, 1971-2000 Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society Mortality after hospitalization for COPD. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Toward a consensus definition for COPD exacerbations Non-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: long term survival and predictors of in-hospital outcome Economic burden of chronic obstructive pulmonary disease. Impact of new treatment options Pharmacoeconomic Evaluation of Acute Exacerbations of Chronic Bronchitis and COPD Meaningful effect size and patterns of response of the transition dyspnea index
author name string	wds:Q37284889-3F40896D-7583-46FE-BF38-BDB23C674F02 wds:Q37284889-D533DDE4-9856-4CBD-BD0E-53D303CCA285 wds:Q37284889-DA39BF57-61AE-42F8-AE83-3760FF07D41C
author name string	S Kesten A Anzueto I Leimer
rdfs:label	Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes (en) Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes (nl) Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes (ast)
skos:prefLabel	Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes (en) Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes (nl) Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes (ast)
name	Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes (en) Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes (nl) Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes (ast)
title	wds:Q37284889-D8A7DADB-B33D-4F02-B604-F8A43B708E47
title	Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes (en)
page(s)	wds:Q37284889-B271E095-F614-4EEA-BC05-7472020C3812
page(s)	245-251

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software